ANNOUNCEMENT

Join us at MedCity CONVERGE July 9-10 in Philadelphia, and hear from ALL healthcare innovation sectors.

How to improve individual site compliance: Emphasize ongoing research training

September 25, 2012 8:00 am by | 1 Comments (Sponsored)

This post is sponsored by IMARC Research, Inc.

Compliance with the Federal Regulations, Agreements with the Sponsor, Investigational Plan, and Requirements of the IRB play a vital role in the FDA approval process. Effective training of the study team is a key component to a site’s overall success and compliance. No matter the “sport” (device or drug), “position” on the team (sponsor, investigator, monitor or coordinator) everyone is working toward FDA approval. A true victory!

When focusing on site compliance, there are many factors to consider. Although it is the Investigator who is responsible for the conduct of the study, there is a larger team at work to complete all the required activities. The research coordinator carries out many of the day-to-day activities and touches nearly every study milestone. With a focus on training and the research coordinator, this whitepaper will piece these two key factors together to give an overall picture of study compliance at the site level.

 

Please take time to download IMARC Research’s newest whitepaper.

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Know What's Next in Medical Innovation

Get the latest stories, carefully selected by our editorial team, in your inbox each morning.


Related Topics:

IMARC Research, Inc.

By IMARC Research, Inc.

More posts by Author

1 comments

Stay Up To Date

Next Story
November stakes are high for all workers – public sector, private sector, and unionized
Close